| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |